Checkpoint blockade in atypical meningiomas episode artwork

EPISODE · Aug 20, 2021 · 39 MIN

Checkpoint blockade in atypical meningiomas

from Neuro-Oncology: The Podcast

Description: Dr. Nicholas Butowski interviews Dr. David Reardon about his recent manuscript "Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results", published online in Neuro-Oncology in May 2021.

NOW PLAYING

Checkpoint blockade in atypical meningiomas

0:00 39:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 39 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on August 20, 2021.

What is this episode about?

Description: Dr. Nicholas Butowski interviews Dr. David Reardon about his recent manuscript "Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results", published online in...

Can I download this Neuro-Oncology: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!